Pharmacokinetics of thioridazine and its metabolites in blood plasma and the brain of rats after acute and chronic treatment

被引:0
|
作者
Daniel, WA
Syrek, M
Mach, A
Wojcikowski, J
Boksa, J
机构
[1] Polish Acad Sci, Inst Pharmacol, Dept Pharmacokinet & Drug Metab, PL-31343 Krakow, Poland
[2] Polish Acad Sci, Inst Pharmacol, Dept Drug Chem, PL-31343 Krakow, Poland
来源
POLISH JOURNAL OF PHARMACOLOGY | 1997年 / 49卷 / 06期
关键词
pharmacokinetics; plasma; brain; thioridazine; mesoridazine; sulforidazine; N-desmethylthioridazine; ring sulfoxide;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This study was aimed at investigation of the pharmacokinetics of thioridazine and its metabolites after a single and repeated administrations. Male Wistar rats received thioridazine as a single dose (10 mg/kg ip) or they were treated chronically with the neuroleptic (10 mg/kg ip, twice a day for two weeks). Plasma and brain concentrations of thioridazine and its metabolites (N-desmethylthioridazine, mesoridazine, sulforidazine, and the ring sulfoxide) were determined using the HPLC method. The obtained data showed that sulfoxidation in position 2 of the thiomethyl substituent and in the thiazine ring are main metabolic pathways of thioridazine, and showed that, in contrast to humans, in the rat N-desmethylthioridazine is formed in appreciable amount. The biotransformation of thioridazine was rather fast yielding plasma peak concentrations of metabolites lower than that of the parent compound. The maximum concentrations of thioridazine and its metabolites in the brain appeared later than in plasma. The peak concentrations and AUC values of thioridazine and its metabolites were higher in the brain than in plasma and this corresponded well with their longer half-lives in the brain as compared to plasma. The drug was not taken up by the brain as efficiently as other phenothiazines, Chronic treatment with thioridazine produced significant increases (with the exception of thioridazine ring sulfoxide) in the plasma concentrations of the parent compound and its metabolites which was accompanied with the prolongation of their plasma half-lives. The observed plasma levels of thioridazine were within 'therapeutic range' while the concentrations of its metabolites were relatively lower as compared to those observed in psychiatric patients. The increased plasma concentrations of thioridazine and its metabolites observed in plasma after chronic treatment were not followed by parallel changes in the brain.
引用
收藏
页码:439 / 452
页数:14
相关论文
共 50 条
  • [1] Interpretation of the pharmacokinetics of ochratoxin A in blood plasma of rats, during and after acute or chronic ingestion
    Mantle, Peter G.
    FOOD AND CHEMICAL TOXICOLOGY, 2008, 46 (05) : 1808 - 1816
  • [2] PLASMA AND BRAIN PHARMACOKINETICS OF AMITRIPTYLINE AND ITS DEMETHYLATED AND HYDROXYLATED METABOLITES AFTER ACUTE INTRAPERITONEAL INJECTION IN MICE
    COUDORE, F
    FIALIP, J
    ESCHALIER, A
    LAVARENNE, J
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1994, 19 (01) : 5 - 11
  • [3] A comprehensive investigation of plasma and brain regional pharmacokinetics of imipramine and its metabolites during and after chronic administration in the rat
    Besret, L
    Debruyne, D
    Rioux, P
    Bonvalot, T
    Moulin, M
    Zarifian, E
    Baron, JC
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 85 (03) : 291 - 295
  • [4] Pharmacokinetics of Midazolam in Plasma and Brain Tissue of Rats after Exposure to Acute and Chronic High Altitude Hypoxia
    Tian, Lu
    Liu, Guiqin
    Zhao, Qin
    Han, Junjun
    Lin, Yue
    Wang, Qian
    Jia, Qiangqiang
    Duo, Delong
    Duan, Yabin
    Zhu, Junbo
    Li, Xiangyang
    HIGH ALTITUDE MEDICINE & BIOLOGY, 2025,
  • [5] Pharmacokinetics and brain distribution of amitraz and its metabolites in rats
    Hu, Steven X.
    Benner, Charles P.
    White, Julie A.
    Martin, Roger A.
    Feenstra, Kenneth L.
    ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY, 2019, 65 : 40 - 45
  • [6] CONCENTRATIONS OF DIAZEPAM AND ITS METABOLITES IN PLASMA AFTER AN ACUTE AND CHRONIC ADMINISTRATION
    KANTO, J
    IISALO, E
    LEHTINEN, V
    SALMINEN, J
    PSYCHOPHARMACOLOGIA, 1974, 36 (02): : 123 - 131
  • [7] PHARMACOKINETICS OF METAPRAMINE AND ITS DEMETHYLATED METABOLITES IN PLASMA AND BRAIN OF MICE
    BOUGEROLLE, AM
    CHABARD, JL
    ESCHALIER, A
    AUMAITRE, O
    FIALIP, J
    DORDAIN, G
    PETIT, J
    BERGER, JA
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1989, 3 (05) : 515 - 525
  • [8] PHARMACOKINETICS OF SULPHINPYRAZONE AND ITS MAJOR METABOLITES AFTER A SINGLE DOSE AND DURING CHRONIC TREATMENT
    SCHLICHT, F
    STAIGER, C
    DEVRIES, J
    GUNDERTREMY, U
    HILDEBRANDT, R
    HARENBERG, J
    WANG, NS
    WEBER, E
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 28 (01) : 97 - 103
  • [9] EFFECTS OF CARBAMAZEPINE ON THE PHARMACOKINETICS AND BRAIN LEVELS OF PHENOBARBITAL AFTER ACUTE AND CHRONIC ADMINISTRATION IN THE RATS
    MENDEZALVAREZ, E
    SOTOOTERO, R
    SIERRAPAREDES, G
    AGUILARVEIGA, E
    GALANVALIENTE, J
    SIERRAMARCUNO, G
    CLINICAL CHEMISTRY, 1990, 36 (06) : 1173 - 1173
  • [10] REGIONAL DISTRIBUTION OF DIAZEPAM AND ITS METABOLITES IN BRAIN OF CAT AFTER CHRONIC TREATMENT
    PLACIDI, GF
    TOGNONI, G
    PACIFICI, GM
    CASSANO, GB
    MORSELLI, PL
    PSYCHOPHARMACOLOGY, 1976, 48 (02) : 133 - 137